Molecular modeling and biophysical analysis of the c-MYC NHE-III1 silencer element

被引:34
作者
Cashman, Derek J. [1 ]
Buscaglia, Robert [1 ]
Freyer, Matthew W. [1 ]
Dettler, Jamie [1 ]
Hurley, Laurence H. [2 ,3 ,4 ,5 ]
Lewis, Edwin A. [1 ]
机构
[1] No Arizona Univ, Dept Chem & Biochem, Flagstaff, AZ 86011 USA
[2] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[3] Arizona Canc Ctr, Tucson, AZ 85724 USA
[4] Univ Arizona, BIO 5 Inst Collabrat Biores, Tucson, AZ 85721 USA
[5] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA
关键词
G-quadruplex; i-Motif; oncogenes; c-MYC; silencer element; NHE III1; TMPyP4;
D O I
10.1007/s00894-007-0254-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G-Quadruplex and i-Motif-forming sequences in the promoter regions of several oncogenes show promise as targets for the regulation of oncogenes. In this study, molecular models were created for the c-MYC NHE-III1 (nuclease hypersensitivity element III1) from two 39-base complementary sequences. The NHE modeled here consists of single folded conformers of the polypurine intramolecular G-Quadruplex and the polypyrimidine intramolecular i-Motif structures, flanked by short duplex DNA sequences. The G-Quadruplex was based on published NMR structural data for the c-MYC 1:2:1 loop isomer. The i-Motif structure is theoretical (with five cytosine-cytosine pairs), where the central intercalated cytosine core interactions are based on NMR structural data obtained for a tetramolecular [d(A(2)C(4))(4)] model i-Motif. The loop structures are in silico predictions of the c-MYC i-motif loops. The porphyrin meso-tetra(N-methyl-4-pyridyl)porphine (TMPyP4), as well as the ortho and meta analogs TMPyP2 and TMPyP3, were docked to six different locations in the complete c-MYC NHE. Comparisons are made for drug binding to the NHE and the isolated G-Quadruplex and i-Motif structures. NHE models both with and without bound cationic porphyrin were simulated for 100 ps using molecular dynamics techniques, and the non-bonded interaction energies between the DNA and porphyrins calculated for all of the docking interactions.
引用
收藏
页码:93 / 101
页数:9
相关论文
共 36 条
[1]   Solution structure of the biologically relevant g-quadruplex element in the human c-MYC promoter. implications for g-quadruplex stabilization [J].
Ambrus, A ;
Chen, D ;
Dai, JX ;
Jones, RA ;
Yang, DZ .
BIOCHEMISTRY, 2005, 44 (06) :2048-2058
[2]   Transcriptional consequences of topoisomerase inhibition [J].
Collins, I ;
Weber, A ;
Levens, D .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (24) :8437-8451
[3]   SITE-SPECIFIC OLIGONUCLEOTIDE BINDING REPRESSES TRANSCRIPTION OF THE HUMAN C-MYC GENE INVITRO [J].
COONEY, M ;
CZERNUSZEWICZ, G ;
POSTEL, EH ;
FLINT, SJ ;
HOGAN, ME .
SCIENCE, 1988, 241 (4864) :456-459
[4]   i-motif solution structure and dynamics of the d(AACCCC) and d(CCCCAA) tetrahymena telomeric repeats [J].
Esmaili, N ;
Leroy, JL .
NUCLEIC ACIDS RESEARCH, 2005, 33 (01) :213-224
[5]   Biophysical studies of the c-MYC NHE III1 promoter:: Model quadruplex interactions with a cationic porphyrin [J].
Freyer, Matthew W. ;
Buscaglia, Robert ;
Kaplan, Kimberly ;
Cashman, Derek ;
Hurley, Laurence H. ;
Lewis, Edwin A. .
BIOPHYSICAL JOURNAL, 2007, 92 (06) :2007-2015
[6]   Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes [J].
Gartel, AL ;
Shchors, K .
EXPERIMENTAL CELL RESEARCH, 2003, 283 (01) :17-21
[7]  
Grand CL, 2002, MOL CANCER THER, V1, P565
[8]   Quadruplex-duplex competition in the nuclease hypersensitive element of human c-myc promoter:: C to T mutation in C-rich strand enhances duplex association [J].
Halder, K ;
Mathur, V ;
Chugh, D ;
Verma, A ;
Chowdhury, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 327 (01) :49-56
[9]   Interactions of TMPyP4 and TMPyP2 with quadruplex DNA. Structural basis for the differential effects on telomerase inhibition [J].
Han, FXG ;
Wheelhouse, RT ;
Hurley, LH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (15) :3561-3570
[10]   G-quadruplex DNA: a potential target for anti-cancer drug design [J].
Han, HY ;
Hurley, LH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (04) :136-142